By Business/Source
Currency:EUR
2025/FY
Stock NameRevenueRatio
Discovery and development of innovative, RNA based therapeutics15.91M100.00%
By Country/Region
Currency:EUR
2025/FY
Stock NameRevenueRatio
United States15.91M100.00%